Standardized oral care using human milk for premature infants in the NICU
Official title: Frequent Standardized Oral Care Using Human Milk to Prevent Oral Dysbiosis and Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit
Run by University of Florida · NCT06000761 · Data updated 2026-11-12
This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Hour to 3 Days |
| Sex | All |
| Enrollment | 218 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | November 23, 2023 |
| Main results expected | September 23, 2026 |
| Study ends | December 20, 2026 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT06000761 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are mothers aged 18 or older with infants born at or before 30 weeks gestation and weighing 1500 grams or less.
✕Probably not a fit
Patients with congenital anomalies of the face, lungs, or gastrointestinal system, or those not expected to survive more than 7 days after delivery, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of frequent standardized oral care on very low birth weight (VLBW) infants in the neonatal intensive care unit (NICU). It aims to address the lack of established guidelines for oral care in this vulnerable population, which is at high risk for complications such as ventilator-associated pneumonia and bronchopulmonary dysplasia. The study will follow 168 VLBW infants for four weeks after birth to assess the effects of this intervention on their health outcomes. By developing evidence-based guidelines, the research seeks to improve the overall care and health of these infants.
Why it matters
Potential benefit: If successful, this study could lead to improved health outcomes and reduced complications for premature infants in NICUs.
How similar studies have gone: While similar approaches have shown success in critically ill adults, this specific intervention for VLBW infants is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: * Mother ≥18 years of age * ≤ 30 weeks gestation * Born weighing ≤ 1500 grams Exclusion: * Congenital anomalies of the face, lungs, or gastrointestinal system * Not expected to live \> 7 days following delivery.
Where it's running
-
Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Leslie Parker, PHD — University of Florida
- Study coordinator: Leslie A Parker, PhD, APRN
- Email: parkela@ufl.edu
- Phone: 352-273-6384
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
-
Lung Ultrasound Score to predict BPD in very preterm babies
This study tests whether lung ultrasound scores in the first two weeks of life can predict which extremely preterm babies will develop bronchopulmonary dysplasia.
-
Multicenter chest X-ray screening for thoracic diseases
This project will test whether routine chest X-rays can detect thoracic problems in adults who come for routine health examinations.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
IVIG for bronchopulmonary dysplasia in infants born at 28 weeks or earlier
This trial will try intravenous immunoglobulin (IVIG) given over five days to see if it helps very preterm infants (≤28 weeks) who show early signs of bronchopulmonary dysplasia.
-
B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation
This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.